Position in RGNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,539,510
+$6,142,822 QoQ
Shares Held
712,814
+149.2% QoQ
Ownership
1.08%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#15
of 164 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. RGNX ranks #79 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in RGNX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,539,510 | 712,814 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,396,688 | 286,001 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $984,787 | 68,388 | Shares | Defined | 2026-02-17 | |
| 2024-12-31 | $489,904 | 63,377 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $578,061 | 55,106 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,669,226 | 142,669 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,290,290 | 156,160 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,829,638 | 157,640 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $734,576 | 44,628 | Shares | Defined | 2023-11-14 | |
| 2022-12-31 | $277,807 | 12,249 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $434,747 | 16,449 | Shares | Defined | 2022-11-14 | |
| 2021-09-30 | $2,527,900 | 60,303 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $10,169,763 | 261,770 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $8,739,834 | 256,225 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $6,594,753 | 145,387 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,728,381 | 135,479 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,943,793 | 107,081 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,984,237 | 92,163 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||